Bickell NA, Aufses AH Jr, Chassin MR: The quality of early-stage breast cancer care. Ann Surg 232:220, 2000.
Bland KI, Copeland EM III (eds): The Breast: Comprehensive Management of Benign and Malignant Diseases, 2nd ed. Philadelphia, WB Saunders, 1998.
Burnet K: Holistic Breast Care. Philadelphia, WB Saunders, 2001.
Campbell HS, Fletcher SW, Lin S: Improving physicians' and nurses' clinical breast examination: A randomized controlled trial. Am J Prev Med 7:1, 1991.
Cancer Facts & Figures. Atlanta, American Cancer Society, 2007.
Collins FS: BRCA1: Lots of mutations, lots of dilemmas. N Engl J Med 334:186, 1996.
Couch FJ, DeShano ML, Blackwood A, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409, 1997.
Dixon JM, Morrow M: Breast Disease: A Problem-Based Approach. Philadelphia, WB Saunders, 1999.
Domchek SM, Antoniou A: Cancer risk models: Translating family history into clinical management. Ann Intern Med 147:515, 2007.
Easton DF, Ford D, Bishop DT, et al: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265, 1995.
Feig SA, Schwartz GF, Nerlinger R, et al: Prognostic factors of breast neoplasms detected on screening by mammography and physical examination. Radiology 133:577, 1979.
Feuer EJ, Wun LM: DEVCAN: Probability of Developing or Dying of Cancer Software, Version 4.0. Bethesda, MD, National Cancer Institute, 1999.
Fletcher SW, O'Malley MS, Earp JL, et al: How best to teach women breast self-examination: A randomized controlled trial. Ann Intern Med 112:772, 1990.
Ford D, Easton DF: The genetics of breast and ovarian cancer. Br J Cancer 72:805, 1995.
Ghafoor A, Jemal A, Cokkinides V, et al: Cancer statistics for African Americans. CA Cancer J Clin 52:326, 2002.
Ghafoor A, Jemal A, Ward E, et al: Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53:342, 2003.
Healy B: BRCA genes: Bookmaking, fortunetelling, and medical care. N Engl J Med 336:1448, 1997.
Hicks MJ, Davis JR, Layton JM, et al: Sensitivity of mammography and physical examination of the breast for detecting breast cancer. JAMA 242:2080, 1979.
Hughes LE, Mansel RE, Webster DJT: Benign Disorders and Diseases of the Breast, 2nd ed. Philadelphia, WB Saunders, 1999.
Jaiyesimi IA, Buzdar AU, Sahin AA, et al: Carcinoma of the male breast. Ann Intern Med 117:771, 1992.
Jemel A, Tiwari R, Murray T, et al: Cancer Statistics, 2004. CA Cancer J Clin 54:8, 2004.
Krainer M, Silva-Arrieta S, FitzGerald MG, et al: Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 336:1416, 1997.
Malumbres M, Baracid M: Timeline: RAS oncogenes: The first 30 years. Nat Rev Cancer 3:459, 2003.
Parmigiani G, Chen S, Iversen ES, et al: Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441, 2007.
Pennypacker HS, Pilgrim CA: Achieving competence in clinical breast examination. Nurse Pract 4:85, 1993.
Rebbeck TR, Lynch HT, Neuhausen SL, et al: Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 346:1616, 2002.
Roses DF: Breast Cancer. Philadelphia, WB Saunders, 1999.
Schulman JD, Stern HJ: Genetic predisposition testing for breast cancer. Cancer J Sci Am 2:244, 1996.
Smith IE, Dowsett M: Aromatase inhibitors in breast cancer. N Engl J Med 348:2431, 2003.
Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 54:41, 2004.
Smith RA, Saslow D, Sawyer KA, et al: American Cancer Society guidelines for breast cancer screening: Update 2003. CA Cancer J Clin 53:141, 2003.
Struewing JP, Hartge P, Wacholder S, et al: The risk of developing cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401, 1997.
Surveillance, Epidemiology, and End Results (SEER) Program: SEER Stat Database: Incidence—SEER 9 Regs Public-Use, November 2002 Sub (1973-2000). Bethesda, Md, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch. Released April 2003, based on the November 2002 submission. Available at www.seer.cancer/gov; accessed June 23, 2008.
Thomas DB, Gao DL, Self SG, et al: Randomized trial of breast self-examination in Shanghai: Methodology and preliminary results. J Natl Cancer Inst 89:355, 1997.
U.S. Mortality 1973-1996, National Center for Health Statistics, Centers for Disease Control and Prevention 1999, Surveillance, Epidemiology, and End Results Program. Bethesda, Md, National Cancer Institute, Division of Cancer Control and Population Sciences, 2000.
U.S. Preventive Services Task Force: Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations (clinical guidelines). Ann Intern Med 143:355, 2005.
Venet L, Strax P, Venet W, et al: Adequacies and inadequacies of breast examination by physicians in mass screening. Cancer 28:1546, 1971.
Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171, 2002.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.